PROTEOMICS INT LAB ORDINARY (PIQ) Short Interest
PROTEOMICS INT LAB ORDINARY (ASX:PIQ) had 0.47% of shares reported as short positions as of 16 July 2026, representing 775,059 shares. PROTEOMICS INT LAB ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Proteomics International Laboratories
Proteomics International Laboratories Ltd (ASX:PIQ) is a medical technology company specializing in predictive diagnostics and bio-analytical services. They focus on proteomics, the industrial-scale study of protein structure and function, to develop novel diagnostic tests like PromarkerD, PromarkerEndo, and PromarkerEso, aiming to bring these to global markets.
Short position
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4PIQ intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Proteomics International Laboratories
About
website
address
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss PIQ
Start a research thread or post the first pulse update